\-\ Texto\\:\\ \ \(0\)\
\-\ recent\\ laboratory\\:\\ alkaline\\ phosphate\\ 301\\ u\\/l\\ \ \(0\)\
\-\ \\(normal\\ 38\\-126\\)\\,\\ other\\ basic\\ lab\\ results\\ normal\\.\ \(0\)\
\-\ tx\\:\\ biphosphonates\\ \\(older\\ tx\\ calcitonin\\)\ \(0\)\
\-\ focal\\ radiotracer\\ uptake\\ within\\ the\\ right\\ hemi\\-pelvis\\.\\ diffuse\\ radiotracer\\ uptake\\ within\\ the\\ right\\ shoulder\\ and\\ lower\\ lumbar\\ spine\\ consistent\\ with\\ degenerative\\ changes\\.\ \(0\)\
\-\ radiograph\\ of\\ the\\ pelvis\\ demonstrates\\ dense\\ sclerotic\\ trabeculae\\ and\\ lytic\\ areas\\ within\\ the\\ right\\ pelvis\\.\\ there\\ is\\ mild\\ cortical\\ expansion\\.\ \(0\)\
\-\ radiograph\\ of\\ the\\ skull\\ demonstrates\\ focal\\ lucency\\ across\\ the\\ anterior\\ portion\\ of\\ the\\ skull\\ consistent\\ with\\ osteoporosis\\ circumscripta\\.\ \(0\)\
\-\ paget\\ disease\\ of\\ bone\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ arthritis\ \(395\)\
\-\ osteomyelitis\ \(170\)\
\-\ paget\\‚\\Ä\\ôs\\ disease\ \(0\)\
\-\ metabolic\\ dz\ \(0\)\
\-\ fibrous\\ dysplasia\\,\\ osteopetrosis\\,\\ osteogenesis\\ imperfecta\\,\\ melorheostosis\ \(0\)\
\-\ trauma\ \(1087\)\
\-\ 77\\ year\\ old\\ with\\ \\‚\\Ä\\úabnormal\\ prior\\ skull\\ radiograph\\‚\\Ä\\¶bone\\ pain\\‚\\Ä\\¶concern\\ for\\ metastatic\\ disease\\.\\‚\\Ä\\ù\ \(1\)\
\-\ disorder\\ of\\ middle\\-aged\\/older\\ individuals\\.\\ \\(3\\%\\ over\\ 40\\)\ \(0\)\
\-\ causes\\ bone\\ pain\\,\\ tenderness\\.\\ increased\\ risk\\ of\\ osteosarcoma\ \(0\)\
\-\ bony\\ proliferation\\ disease\\ characterized\\ by\\ excessive\\ and\\ abnormal\\ remodeling\\ of\\ bone\\:\\ sclerosis\\,\\ thickened\\ trabeculae\\,\\ and\\ enlargement\\.\ \(0\)\
\-\ 3\\ phases\\:\\ lytic\\,\\ mixed\\ lytic\\-sclerotic\\,\\ sclerotic\ \(0\)\
\-\ viral\\ etiology\\ has\\ been\\ considered\\.\ \(0\)\
\-\ elevated\\ alkaline\\ phosphatase\\,\\ 20\\%\\ monostotic\ \(0\)\
\-\ tx\\:\\ biphosphonates\\ \\(older\\ tx\\ calcitonin\\)\ \(0\)\
\-\ bone\\ scintigraphy\\:can\\ be\\ used\\ to\\ diagnose\\,\\ evaluate\\ extent\\,\\ and\\ evaluate\\ treatment\\ with\\ biphosphonates\\.\ \(0\)\
\-\ findings\\:\\ increased\\ uptake\\ along\\ cortico\\-medulary\\ bone\\,\\ sharp\\ leading\\ edge\\ \\‚\\Ä\\úflame\\-shaped\\‚\\Ä\\ù\\ or\\ \\‚\\Ä\\úblade\\-of\\-grass\\‚\\Ä\\ù\\,\\ bony\\ enlargement\\,\\ bowing\\ of\\ femur\\.\\ \ \(0\)\
\-\ location\\:\\ skull\\,\\ tubular\\ bones\\ \\(diaphysis\\)\\,\\ pelvis\\,\\ spine\\.\ \(0\)\
\-\ f\\-18\\-fdg\\ pet\\ not\\ helpful\\.\ \(0\)\
\-\ brown\\ ml\\.\\ bone\\ scintigraphy\\ in\\ benign\\ and\\ malignant\\ tumors\\.\\ radiol\\ clin\\ north\\ am\\ 31\\;731\\-738\\,\\ 1993\\.\ \(0\)\
\-\ hain\\ sf\\,\\ fogelman\\ i\\.\\ nuclear\\ medicine\\ studies\\ in\\ metabolic\\ bone\\ disease\\.\\ seminars\\ musculoskeletal\\ radiology\\ 6\\(4\\)\\;323\\-329\\,\\ 2002\\.\ \(0\)\
\-\ cook\\ gj\\,\\ maisey\\ mn\\,\\ fogelman\\ i\\.\\ fluorine\\-18\\-fdg\\ pet\\ in\\ paget\\‚\\Ä\\ôs\\ disease\\ of\\ bone\\.\\ j\\ nucl\\ med\\ 8\\(9\\)\\;1495\\-1497\\,\\ 1997\\.\ \(0\)\
\-\ resnick\\ d\\,\\ kransdorf\\ mj\\.\\ bone\\ and\\ joint\\ imaging\\.\\ 3rd\\ edition\\,\\ elsevier\\-saunders\\.\\ 576\\-588\\,\\ 2005\\.\ \(0\)\
\-\ thrall\\ jh\\,\\ ziessman\\ ha\\.\\ nuclear\\ medicine\\:\\ the\\ requisites\\.\\ 2nd\\ ed\\.\\,\\ mosby\\.chapter\\ 6\\,\\ 2001\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bone\\:\\ 0\\.2785591604958669\ \(0\)\
\-\ biphosphonates\\:\\ 0\\.24493289584830305\ \(0\)\
\-\ tx\\:\\ 0\\.22411322944979364\ \(0\)\
\-\ skull\\:\\ 0\\.16568788989590627\ \(0\)\
\-\ fogelman\\:\\ 0\\.16328859723220204\ \(0\)\
\-\ paget\\:\\ 0\\.1518804537589576\ \(0\)\
\-\ disease\\:\\ 0\\.1500106162941933\ \(0\)\
\-\ pelvis\\:\\ 0\\.1428261285545626\ \(0\)\
\-\ older\\:\\ 0\\.1421367100397217\ \(0\)\
\-\ calcitonin\\:\\ 0\\.1363663544942109\ \(0\)\
\-\ lytic\\:\\ 0\\.12901153775182292\ \(0\)\
\-\ sclerotic\\:\\ 0\\.12847985187575658\ \(0\)\
\-\ trabeculae\\:\\ 0\\.12299158565152189\ \(0\)\
\-\ uptake\\:\\ 0\\.11776947537911675\ \(0\)\
\-\ alkaline\\:\\ 0\\.1148158357792327\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.10603392782838034\ \(0\)\
\-\ of\\:\\ 0\\.09990777276898508\ \(0\)\
\-\ radiograph\\:\\ 0\\.09975433861188007\ \(0\)\
\-\ nuclear\\:\\ 0\\.09660052451042096\ \(0\)\
\-\ pet\\:\\ 0\\.09456429663295968\ \(0\)\
\-\ metabolic\\:\\ 0\\.09256328566471819\ \(0\)\
\-\ medicine\\:\\ 0\\.0900018512220739\ \(0\)\
\-\ radiotracer\\:\\ 0\\.08912853137443094\ \(0\)\
\-\ hain\\:\\ 0\\.08164429861610102\ \(0\)\
\-\ maisey\\:\\ 0\\.08164429861610102\ \(0\)\
\-\ the\\:\\ 0\\.08149482548431168\ \(0\)\
\-\ evaluate\\:\\ 0\\.07939808330004439\ \(0\)\
\-\ bony\\:\\ 0\\.07867068950698718\ \(0\)\
\-\ enlargement\\:\\ 0\\.07827899978058923\ \(0\)\
\-\ cook\\:\\ 0\\.07801548600124808\ \(0\)\
\-\ 301\\:\\ 0\\.07544080247681131\ \(0\)\
\-\ sf\\:\\ 0\\.07544080247681131\ \(0\)\
\-\ and\\:\\ 0\\.07384583296191032\ \(0\)\
\-\ circumscripta\\:\\ 0\\.07344372278304868\ \(0\)\
\-\ seminars\\:\\ 0\\.07344372278304868\ \(0\)\
\-\ kransdorf\\:\\ 0\\.07344372278304868\ \(0\)\
\-\ gj\\:\\ 0\\.07181198986195839\ \(0\)\
\-\ within\\:\\ 0\\.07053982639644557\ \(0\)\
\-\ mn\\:\\ 0\\.07043237933479045\ \(0\)\
\-\ nucl\\:\\ 0\\.07043237933479045\ \(0\)\
\-\ mj\\:\\ 0\\.07043237933479045\ \(0\)\
\-\ melorheostosis\\:\\ 0\\.06923730633752163\ \(0\)\
\-\ monostotic\\:\\ 0\\.06818317724710544\ \(0\)\
\-\ ziessman\\:\\ 0\\.06818317724710544\ \(0\)\
\-\ spine\\:\\ 0\\.06745061350076324\ \(0\)\
\-\ osteopetrosis\\:\\ 0\\.06638722406503754\ \(0\)\
\-\ thrall\\:\\ 0\\.06638722406503754\ \(0\)\
\-\ phosphate\\:\\ 0\\.06560849372266869\ \(0\)\
\-\ dz\\:\\ 0\\.06361141402890605\ \(0\)\
\-\ jh\\:\\ 0\\.06361141402890605\ \(0\)\
\-\ radiol\\:\\ 0\\.061979681107815744\ \(0\)\
\-\ resnick\\:\\ 0\\.061979681107815744\ \(0\)\
\-\ abnormal\\:\\ 0\\.06134349481452365\ \(0\)\
\-\ focal\\:\\ 0\\.06107477324358389\ \(0\)\
\-\ imperfecta\\:\\ 0\\.05978589562515329\ \(0\)\
\-\ osteogenesis\\:\\ 0\\.059404997583378985\ \(0\)\
\-\ ha\\:\\ 0\\.059404997583378985\ \(0\)\
\-\ north\\:\\ 0\\.059039650810706654\ \(0\)\
\-\ phases\\:\\ 0\\.0586886351109385\ \(0\)\
\-\ phosphatase\\:\\ 0\\.0586886351109385\ \(0\)\
\-\ requisites\\:\\ 0\\.05802538705621105\ \(0\)\
\-\ bowing\\:\\ 0\\.0577113284073741\ \(0\)\
\-\ basic\\:\\ 0\\.05740791788961635\ \(0\)\
\-\ diagnose\\:\\ 0\\.05711445707062248\ \(0\)\
\-\ remodeling\\:\\ 0\\.05683031405894223\ \(0\)\
\-\ brown\\:\\ 0\\.056287738660914445\ \(0\)\
\-\ metastatic\\:\\ 0\\.05599964730583951\ \(0\)\
\-\ consistent\\:\\ 0\\.055363835597939816\ \(0\)\
\-\ increased\\:\\ 0\\.05521368906909446\ \(0\)\
\-\ excessive\\:\\ 0\\.055059822496085556\ \(0\)\
\-\ proliferation\\:\\ 0\\.05483323436517959\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.054396574441358106\ \(0\)\
\-\ edition\\:\\ 0\\.054185982298832494\ \(0\)\
\-\ clin\\:\\ 0\\.05358239948586359\ \(0\)\
\-\ individuals\\:\\ 0\\.0533899242586669\ \(0\)\
\-\ edge\\:\\ 0\\.0515078322680844\ \(0\)\
\-\ med\\:\\ 0\\.05135484130985516\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0512965905784434\ \(0\)\
\-\ 77\\:\\ 0\\.051056488578678096\ \(0\)\
\-\ right\\:\\ 0\\.05077819564219334\ \(0\)\
\-\ sharp\\:\\ 0\\.050216833881798956\ \(0\)\
\-\ across\\:\\ 0\\.04969786224193549\ \(0\)\
\-\ diaphysis\\:\\ 0\\.04969786224193549\ \(0\)\
\-\ helpful\\:\\ 0\\.04840874543940896\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.04840874543940896\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.04830026225521048\ \(0\)\
\-\ am\\:\\ 0\\.048193078302068405\ \(0\)\
\-\ 2001\\:\\ 0\\.048193078302068405\ \(0\)\
\-\ viral\\:\\ 0\\.04709172085341891\ \(0\)\
\-\ characterized\\:\\ 0\\.04690526091923438\ \(0\)\
\-\ extent\\:\\ 0\\.046722606556752255\ \(0\)\
\-\ 2nd\\:\\ 0\\.046722606556752255\ \(0\)\
\-\ 3rd\\:\\ 0\\.04663265853212725\ \(0\)\
\-\ expansion\\:\\ 0\\.046543605527565625\ \(0\)\
\-\ ml\\:\\ 0\\.04619599860830577\ \(0\)\
\-\ lab\\:\\ 0\\.04611116619005972\ \(0\)\
\-\ leading\\:\\ 0\\.04538182365281125\ \(0\)\
\-\ 31\\:\\ 0\\.045304336128794705\ \(0\)\
\-\ dense\\:\\ 0\\.04500092561103695\ \(0\)\
\-\ tubular\\:\\ 0\\.04435367354468986\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.04401333774250927\ \(0\)\
\-\ lucency\\:\\ 0\\.04394679652062077\ \(0\)\
\-\ degenerative\\:\\ 0\\.043369192689946656\ \(0\)\
\-\ disorder\\:\\ 0\\.043184655160047526\ \(0\)\
\-\ thickened\\:\\ 0\\.043063710709821984\ \(0\)\
\-\ mixed\\:\\ 0\\.04225998802192873\ \(0\)\
\-\ femur\\:\\ 0\\.04188366668857241\ \(0\)\
\-\ normal\\:\\ 0\\.04168890785076124\ \(0\)\
\-\ arthritis\\:\\ 0\\.04152253255571252\ \(0\)\
\-\ lumbar\\:\\ 0\\.041224179824535453\ \(0\)\
\-\ etiology\\:\\ 0\\.04112689894155977\ \(0\)\
\-\ bones\\:\\ 0\\.04107865217719014\ \(0\)\
\-\ radiology\\:\\ 0\\.04088822471412922\ \(0\)\
\-\ with\\:\\ 0\\.03998698705576313\ \(0\)\
\-\ results\\:\\ 0\\.039781910326490456\ \(0\)\
\-\ considered\\:\\ 0\\.039781910326490456\ \(0\)\
\-\ shoulder\\:\\ 0\\.039657893287346306\ \(0\)\
\-\ fibrous\\:\\ 0\\.039657893287346306\ \(0\)\
\-\ dysplasia\\:\\ 0\\.03910083998950501\ \(0\)\
\-\ causes\\:\\ 0\\.038576436685266315\ \(0\)\
\-\ used\\:\\ 0\\.03821982564107314\ \(0\)\
\-\ in\\:\\ 0\\.03810072598786126\ \(0\)\
\-\ 40\\:\\ 0\\.03754659459243125\ \(0\)\
\-\ tumors\\:\\ 0\\.03754659459243125\ \(0\)\
\-\ studies\\:\\ 0\\.037449839562337196\ \(0\)\
\-\ laboratory\\:\\ 0\\.03707295216509174\ \(0\)\
\-\ cortical\\:\\ 0\\.03665241660633606\ \(0\)\
\-\ pain\\:\\ 0\\.03653703263874586\ \(0\)\
\-\ portion\\:\\ 0\\.03650688895899074\ \(0\)\
\-\ risk\\:\\ 0\\.03647806525254255\ \(0\)\
\-\ malignant\\:\\ 0\\.03639214696276929\ \(0\)\
\-\ sclerosis\\:\\ 0\\.03636368985416313\ \(0\)\
\-\ location\\:\\ 0\\.03554951489866861\ \(0\)\
\-\ benign\\:\\ 0\\.03506972355104852\ \(0\)\
\-\ elevated\\:\\ 0\\.034803270084221974\ \(0\)\
\-\ areas\\:\\ 0\\.03466120752814392\ \(0\)\
\-\ recent\\:\\ 0\\.03456773667209522\ \(0\)\
\-\ along\\:\\ 0\\.034203319792209454\ \(0\)\
\-\ joint\\:\\ 0\\.033641073158077815\ \(0\)\
\-\ 20\\:\\ 0\\.03293600375100492\ \(0\)\
\-\ diffuse\\:\\ 0\\.03201632950178344\ \(0\)\
\-\ tenderness\\:\\ 0\\.03201632950178344\ \(0\)\
\-\ changes\\:\\ 0\\.030854091638996238\ \(0\)\
\-\ been\\:\\ 0\\.029743851059973465\ \(0\)\
\-\ trauma\\:\\ 0\\.02964942927713667\ \(0\)\
\-\ mild\\:\\ 0\\.028940294756841484\ \(0\)\
\-\ prior\\:\\ 0\\.028564046340134788\ \(0\)\
\-\ anterior\\:\\ 0\\.028504815461359724\ \(0\)\
\-\ over\\:\\ 0\\.0283875168869305\ \(0\)\
\-\ imaging\\:\\ 0\\.02682989435192892\ \(0\)\
\-\ can\\:\\ 0\\.02679081239848653\ \(0\)\
\-\ other\\:\\ 0\\.026512459839027083\ \(0\)\
\-\ lower\\:\\ 0\\.026087958989918614\ \(0\)\
\-\ findings\\:\\ 0\\.02519652960421065\ \(0\)\
\-\ treatment\\:\\ 0\\.024319085263052615\ \(0\)\
\-\ has\\:\\ 0\\.02331936213420283\ \(0\)\
\-\ by\\:\\ 0\\.021679915333202085\ \(0\)\
\-\ be\\:\\ 0\\.02071001838840205\ \(0\)\
\-\ there\\:\\ 0\\.02031369026605602\ \(0\)\
\-\ not\\:\\ 0\\.020154371081974837\ \(0\)\
\-\ or\\:\\ 0\\.017760307235092344\ \(0\)\
\-\ year\\:\\ 0\\.015733421024929313\ \(0\)\
\-\ for\\:\\ 0\\.015473665847292817\ \(0\)\
\-\ old\\:\\ 0\\.015109530442777411\ \(0\)\
\-\ is\\:\\ 0\\.01398111455313373\ \(0\)\
\-\ to\\:\\ 0\\.012763061759500807\ \(0\)\
